Quell Therapeutics Advances QEL-001, Its Multi-Modular Engineered CAR-Treg Cell Therapy, Into Efficacy Cohort Of LIBERATE Phase 1/2 Trial In Liver Tra...
Progress in the LIBERATE trial was presented at the American Transplant
Source: menafn.com
Luke Devey News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Luke Devey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Luke Devey Today - Breaking & Trending Today
Quell Therapeutics Appoints Luke Devey, BMBCh, Ph.D. as Chief Medical Officer
/PRNewswire/ -- Quell Therapeutics Ltd ("Quell"), a world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions...
Source: prnewswire.com
Collaborating With Academia For Drug Discovery Targeting Immune-Mediated Diseases
Last year, Janssen Biotech and the University of Oxford established a collaboration to understand pathogenic pathways driving immune-mediated...
Source: pharmaceuticalonline.com